These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 9330405)

  • 1. Combined-modality therapy of head and neck cancer.
    Vokes EE
    Oncology (Williston Park); 1997 Sep; 11(9 Suppl 9):27-30. PubMed ID: 9330405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of chemotherapy in the curative treatment of head and neck cancer.
    Pfister DG; Shaha AR; Harrison LB
    Surg Oncol Clin N Am; 1997 Oct; 6(4):749-68. PubMed ID: 9309092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy in the management of squamous-cell carcinoma of the head and neck.
    Lamont EB; Vokes EE
    Lancet Oncol; 2001 May; 2(5):261-9. PubMed ID: 11905780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of combined modality therapies for head and neck cancer.
    Dimery IW; Hong WK
    J Natl Cancer Inst; 1993 Jan; 85(2):95-111. PubMed ID: 8418313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).
    Bernier J; Cooper JS; Pajak TF; van Glabbeke M; Bourhis J; Forastiere A; Ozsahin EM; Jacobs JR; Jassem J; Ang KK; Lefèbvre JL
    Head Neck; 2005 Oct; 27(10):843-50. PubMed ID: 16161069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy for head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2000 Feb; 27(2):177-82. PubMed ID: 10700887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.
    Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL
    J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of Chemotherapy in head and neck cancer].
    Kohno N; Kitahara S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):448-53. PubMed ID: 11329777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of head and neck cancer.
    LaFollette S; Taylor SG
    Cancer Chemother Biol Response Modif; 1996; 16():462-73. PubMed ID: 8639394
    [No Abstract]   [Full Text] [Related]  

  • 10. Does concurrent postoperative radiotherapy and chemotherapy in head and neck cancer improve patient outcome?
    Yom SS; Rosenthal DI
    Nat Clin Pract Oncol; 2004 Nov; 1(1):14-5. PubMed ID: 16264790
    [No Abstract]   [Full Text] [Related]  

  • 11. Individual patients' data meta-analyses in head and neck cancer.
    Bourhis J; Le Maître A; Baujat B; Audry H; Pignon JP; ; ;
    Curr Opin Oncol; 2007 May; 19(3):188-94. PubMed ID: 17414635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined-modality therapy for locoregionally advanced head and neck cancer.
    Cmelak AJ; Murphy BA; Day T
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):83-91. PubMed ID: 10550831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined-modality therapy for head and neck cancer.
    Fu KK
    Oncology (Williston Park); 1997 Dec; 11(12):1781-90, 1796; discussion 1796, 179. PubMed ID: 9436185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in head and neck cancer.
    Hamasaki VK; Vokes EE
    Curr Opin Oncol; 1992 Jun; 4(3):504-11. PubMed ID: 1498159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative clinical studies for head and neck cancer in Japan].
    Fujii M
    Gan To Kagaku Ryoho; 2002 Sep; 29(9):1502-8. PubMed ID: 12355935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodality treatment including postoperative radiation and concurrent chemotherapy with weekly docetaxel is feasible and effective in patients with oral and oropharyngeal cancer.
    Kovács AF; Mose S; Böttcher HD; Bitter K
    Strahlenther Onkol; 2005 Jan; 181(1):26-34. PubMed ID: 15660190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer.
    Rengan R; Pfister DG; Lee NY; Kraus DH; Shah JP; Shaha AR; Ben-Porat LS; Zelefsky MJ
    Am J Clin Oncol; 2008 Oct; 31(5):465-9. PubMed ID: 18838883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and emerging standards of concomitant chemoradiotherapy.
    Adelstein DJ; Rodriguez CP
    Semin Oncol; 2008 Jun; 35(3):211-20. PubMed ID: 18544436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.
    Mantovani G; Proto E; Massa E; Mulas C; Madeddu C; Mura L; Mudu MC; Astara G; Murgia V; Gramignano G; Ferreli L; Camboni P; Lusso MR; Mocci M; Tore G; Mura M; Amichetti M; Maccio A
    Int J Oncol; 2002 Feb; 20(2):419-27. PubMed ID: 11788911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of platinum chemotherapy in head and neck cancer.
    Forastiere AA
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):20-7. PubMed ID: 7527591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.